ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling
- PMID: 26201690
- DOI: 10.1016/j.ijcard.2015.06.099
ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling
Abstract
Rationale: Pressure overload induces adaptive remodeling processes in the heart. However, when pressure overload persists, adaptive changes turn into maladaptive alterations leading to cardiac hypertrophy and heart failure. ATF3 is a stress inducible transcription factor that is transiently expressed following neuroendocrine stimulation. However, its role in chronic pressure overload dependent cardiac hypertrophy is currently unknown.
Objective: The objective of the study was to study the role of ATF3 in chronic pressure overload dependent cardiac remodeling processes.
Methods and results: Pressure overload was induced by phenylephrine (PE) mini-osmotic pumps in various mice models of whole body, cardiac specific, bone marrow (BM) specific and macrophage specific ATF3 ablations. We show that ATF3-KO mice exhibit a significantly reduced expression of cardiac remodeling markers following chronic pressure overload. Consistently, the lack of ATF3 specifically in either cardiomyocytes or BM derived cells blunts the hypertrophic response to PE infusion. A unique cross-talk between cardiomyocytes and macrophages was identified. Cardiomyocytes induce an ATF3 dependent induction of an inflammatory response leading to macrophage recruitment to the heart. Adoptive transfer of wild type macrophages, but not ATF3-KO derived macrophages, into wild type mice potentiates maladaptive response to PE infusion.
Conclusions: Collectively, this study places ATF3 as a key regulator in promoting pressure overload induced cardiac hypertrophy through a cross-talk between cardiomyocytes and macrophages. Inhibiting this cross-talk may serve as a useful approach to blunt maladaptive remodeling processes in the heart.
Keywords: Bone marrow transplantation; Cardiac hypertrophy; Cardiac remodeling; Macrophages; Pressure overload.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Comment in
-
ATF3: A promotion effect or a inhibition effect in cardiac maladaptive remodeling.Int J Cardiol. 2015 Dec 15;201:245-6. doi: 10.1016/j.ijcard.2015.08.079. Epub 2015 Aug 11. Int J Cardiol. 2015. PMID: 26301647 No abstract available.
-
Response letter: "ATF3: A promoter or inhibitor of cardiac maladaptive remodeling".Int J Cardiol. 2015 Dec 15;201:692. doi: 10.1016/j.ijcard.2015.08.169. Epub 2015 Aug 28. Int J Cardiol. 2015. PMID: 26374759 No abstract available.
-
ATF3: A potential target for cardiac maladaptive remodeling.Int J Cardiol. 2016 Jan 1;202:50-1. doi: 10.1016/j.ijcard.2015.08.179. Epub 2015 Aug 28. Int J Cardiol. 2016. PMID: 26386920 No abstract available.
Similar articles
-
The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis.Int J Cardiol. 2017 Feb 1;228:394-400. doi: 10.1016/j.ijcard.2016.11.159. Epub 2016 Nov 10. Int J Cardiol. 2017. PMID: 27870968
-
ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.Cardiovasc Res. 2017 Feb;113(2):134-146. doi: 10.1093/cvr/cvw228. Epub 2016 Nov 7. Cardiovasc Res. 2017. PMID: 28082453
-
Pleiotropic and puzzling effects of ATF3 in maladaptive cardiac remodeling.Int J Cardiol. 2016 Mar 1;206:87-8. doi: 10.1016/j.ijcard.2016.01.143. Epub 2016 Jan 8. Int J Cardiol. 2016. PMID: 26780683 No abstract available.
-
Molecular Aspects of Exercise-induced Cardiac Remodeling.Cardiol Clin. 2016 Nov;34(4):515-530. doi: 10.1016/j.ccl.2016.06.002. Epub 2016 Aug 25. Cardiol Clin. 2016. PMID: 27692221 Review.
-
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy.Cells. 2023 Jul 4;12(13):1780. doi: 10.3390/cells12131780. Cells. 2023. PMID: 37443814 Free PMC article. Review.
Cited by
-
Molecular profiling of dilated cardiomyopathy that progresses to heart failure.JCI Insight. 2016 May 5;1(6):e86898. doi: 10.1172/jci.insight.86898. JCI Insight. 2016. PMID: 27239561 Free PMC article.
-
JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?Int J Mol Sci. 2021 Apr 16;22(8):4110. doi: 10.3390/ijms22084110. Int J Mol Sci. 2021. PMID: 33923401 Free PMC article. Review.
-
Toll-like Receptor 4 Differentially Modulates Cardiac Function in Response to Chronic Exposure to High-Fat Diet and Pressure Overload.Nutrients. 2023 Dec 18;15(24):5139. doi: 10.3390/nu15245139. Nutrients. 2023. PMID: 38140398 Free PMC article.
-
JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function.PLoS One. 2019 Feb 28;14(2):e0213081. doi: 10.1371/journal.pone.0213081. eCollection 2019. PLoS One. 2019. PMID: 30818334 Free PMC article.
-
ATF3 expression in cardiomyocytes and myofibroblasts following transverse aortic constriction displays distinct phenotypes.Int J Cardiol Heart Vasc. 2020 Dec 29;32:100706. doi: 10.1016/j.ijcha.2020.100706. eCollection 2021 Feb. Int J Cardiol Heart Vasc. 2020. PMID: 33437861 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous